Function

Function

Function was founded in 2021 by Spotify founder Daniel Ek, clinician-scientist Hjalmar Nilsonne, and Harvard AI researcher Pranav Rajpurkar. The company addresses a structural gap in healthcare: episodic, symptom-triggered lab work that misses asymptomatic disease. By offering a direct-to-consumer membership that covers biannual panels of more than 100 biomarkers — ranging from heavy metals and autoimmune markers to advanced lipids and cancer screening — Function positions itself outside traditional insurance-reimbursement pathways, competing instead with concierge medicine and executive physicals. Ek's experience scaling Spotify's platform informs the operational architecture, while Nilsonne and Rajpurkar bring clinical measurement design and machine-learning rigor to the underlying data models. The company operates without disclosed institutional capital from traditional family offices or sovereign wealth funds, instead relying on a venture financing structure led by prominent technology investors including Andreessen Horowitz, which co-led a Series A round, and Thrive Capital. The firm's deployment strategy centers on scaling a high-complexity, centralized laboratory analysis model paired with a consumer-facing digital dashboard. Function does not operate as a family office or asset manager; its capital allocation is directed entirely toward operating infrastructure — lab partnerships, phlebotomy networks, and proprietary data interpretation software. The platform covers endocrinology, cardiology, immunology, oncology markers, and toxicology, generating what Function describes as a deeply individualized baseline for each member. This approach pits the company against laboratory giants like Quest Diagnostics and Labcorp, though it competes on longitudinal interpretation rather than test volume. Geographically, Function is active across the United States, with physical blood-draw sites established in major metropolitan areas including New York, Los Angeles, and San Francisco. In early 2025, the company reported surpassing 100,000 active members, signaling adoption concentrated in biohacking, longevity-focused, and executive wellness communities (per Function, January 2025). The company is headquartered in New York City and operates without a disclosed number of professionals, though the team includes clinicians, research scientists, and engineers dedicated to the platform's data pipeline. No adjacent philanthropic vehicles or real-asset arms are known to exist. The leadership structure places Ek as Executive Chairman, a role that mirrors his pattern of founding and chairing technology-intensive health and infrastructure ventures adjacent to Spotify. In May 2025, Function opened a dedicated member experience center in Manhattan — its first branded physical space outside its laboratory network — designed to serve as both a clinical intake point and a commercial showroom for prospective members (per Function press release, May 2025). The company has not publicly disclosed any co-investment clubs, peer family office participation, or formal ties to the Tiger 21 or YPO networks. Function's structural distinction lies in its refusal to operate within the electronic health record ecosystem. Rather than integrating with hospital IT systems, the platform builds a parallel, patient-owned data repository that sits outside HIPAA-covered entity relationships through its direct-to-consumer consent model. This architecture avoids the interoperability friction that slows health AI deployments inside health systems, but it also places the company outside referral loops that connect lab results to treating physicians. The governance model — a venture-backed public benefit corporation, with Ek serving as a long-horizon founder-chair — represents a hybrid form: neither a pure technology startup nor a medical practice, but a data company operating on human physiology at scale.